Clinical Trial Update: Beta-glucan Effects on Lipid Profile, Glycemia and inTestinal Health (BELT) [NA]

View source ↗

Summary

An update on a clinical trial evaluating beta-glucan's effects on lipid profiles, glycemic measures, and intestinal health in individuals with atherosclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• Beta Glucan (beta-glucan)

Snippet

Sponsor: University of Bologna | Conditions: Atherosclerosis | NA | Status: UNKNOWN